Thread Expands Collaboration with Datavant
Thread has announced the launch of a tokenization feature on its research platform that connects clinical trial and real-world data. This advancement, which expands Thread's collaboration with Datavant, leverages Datavant's connectivity tools that enable clients to tokenize, match, and link patient records across de-identified datasets while preserving patient privacy in compliance with regulations.
By engaging these tools to connect clinical trial data with real-world data, biopharmaceutical companies can unlock their studies' full potential by generating a longitudinal view of the patient journey. This solution supports advancing research data access to provide a deeper understanding of patient outcomes.
"Thread's enhanced tokenization feature, backed by Datavant's leading de-identification technology, is a powerful shift in the way real-world data can be integrated into clinical trials. Our customers can now gain and integrate their clinical and real-world data in a few clicks to support their goal of generating additional evidence," said Thread Co-Founder and CEO John Reites in a press release.
"Linking clinical trial data with real-world data can yield enormous benefits for both life sciences researchers and patients, by generating better evidence on treatment safety and efficacy while reducing the burden on trial participants," said Tal Rosenberg, president and general manager, life sciences, ecosystem & public sector at Datavant in a press release. "We're thrilled to enhance our use case by embedding Datavant's technology onto Thread's no-code platform and offering the power of connected clinical trials to a broader customer base."
Reference
THREAD EXPANDS DATAVANT PARTNERSHIP TO LAUNCH FULLY CONFIGURABLE SOLUTION FOR REAL-WORLD DATA LINKAGE. (2023, October 3). Cision PR Newswire.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
